NT-proBNP和cTnI联合检测对慢性心力衰竭患者诊断和预后评估价值OA
Diagnosis and prognosia value of combined detection of NT-proBNP and cTnI on patients with chronic heart failure
目的 探讨血清N末端B型钠尿肽原(NT-proBNP)和心肌肌钙蛋白I(cTnI)联合检测对慢性心力衰竭患者诊断和预后评估价值.方法 对本院2009年6月-2011年6月收治的120例慢性心力衰竭患者进行研究:不同NYHA心功能分级的血浆NT-proBNP和cTnI水平;通过随访研究不同NT-proBNP和cTnI水平的心血管事件情况.结果 心衰患者的NT-proBNP和cTnI水平分别为(1664.8±632.9) pg/ml和(0.35±0.…查看全部>>
Objective To explore the diagnosis and prognosis value of combined detection of NT-proBNP and cTnI on patients with chronic heart failure.Methods 120 patients with chronic heart failure in our hospital from June 2009 to June 2011 were studied:the plasma NT-proBNP and cTnI levels at different NYHA class; the cardiovascular events of different NT-proBNP and cTnI levels during follow up.Results The NT-proBNP and cTnI levels of heart failure patients were (16…查看全部>>
王涵;梁服泉;张杰灵;周建球;罗林佳
519070 珠海市香洲区人民医院检验科519070 珠海市香洲区人民医院检验科519070 珠海市香洲区人民医院检验科519070 珠海市香洲区人民医院检验科519070 珠海市香洲区人民医院内科
NT-proBNPcTnI慢性心力衰竭诊断和预后评估
NT-proBNPcTnIChronic heart failureDiagnosis and prognosis
《国际医药卫生导报》 2012 (8)
1170-1172,3
评论